The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response
Merav Cohen
(1, 2, 3)
,
Amir Giladi
(1, 4)
,
Oren Barboy
(1)
,
Pauline Hamon
(3)
,
Baoguo Li
(1)
,
Mor Zada
(1, 2)
,
Anna Gurevich-Shapiro
(1, 2)
,
Cristian Gabriel Beccaria
(5, 6)
,
Eyal David
(1)
,
Barbara Maier
(3)
,
Mark Buckup
(3)
,
Iris Kamer
(7)
,
Aleksandra Deczkowska
(8, 1)
,
Jessica Le Berichel
(3)
,
Jair Bar
(7, 2)
,
Matteo Iannacone
(5, 6)
,
Amos Tanay
(1)
,
Miriam Merad
(3)
,
Ido Amit
(1)
1
Weizmann Institute of Science [Rehovot, Israël]
2 Sackler School of Medicine
3 MSSM - Icahn School of Medicine at Mount Sinai [New York]
4 Hubrecht Institute [Utrecht, Netherlands]
5 IRCCS San Raffaele Scientific Institute [Milan, Italie]
6 UniSR - Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie]
7 Chaim Sheba Medical Center
8 Interactions cerveau-immunité - Brain-immune communication
2 Sackler School of Medicine
3 MSSM - Icahn School of Medicine at Mount Sinai [New York]
4 Hubrecht Institute [Utrecht, Netherlands]
5 IRCCS San Raffaele Scientific Institute [Milan, Italie]
6 UniSR - Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie]
7 Chaim Sheba Medical Center
8 Interactions cerveau-immunité - Brain-immune communication
Matteo Iannacone
- Function : Author
- PersonId : 1142761
- ORCID : 0000-0002-9370-2671
- IdRef : 235785105
Miriam Merad
Connectez-vous pour contacter l'auteur
- Function : Correspondent author
- PersonId : 1062975
Connectez-vous pour contacter l'auteur
Abstract
Despite their key regulatory role and therapeutic potency, the molecular signatures of interactions between T cells and antigen-presenting myeloid cells within the tumor microenvironment remain poorly characterized. Here, we systematically characterize these interactions using RNA sequencing of physically interacting cells (PIC-seq) and find that CD4+PD-1+CXCL13+ T cells are a major interacting hub with antigen-presenting cells in the tumor microenvironment of human non-small cell lung carcinoma. We define this clonally expanded, tumor-specific and conserved T-cell subset as T-helper tumor (Tht) cells. Reconstitution of Tht cells in vitro and in an ovalbumin-specific αβ TCR CD4+ T-cell mouse model, shows that the Tht program is primed in tumor-draining lymph nodes by dendritic cells presenting tumor antigens, and that their function is important for harnessing the antitumor response of anti-PD-1 treatment. Our molecular and functional findings support the modulation of Tht-dendritic cell interaction checkpoints as a major interventional strategy in immunotherapy.